Skip to content Skip to footer
Subscribe Now
Know Your Investor: Janus Henderson Group Plc (April’25 Edition)
INSIGHTS+

Know Your Investor: Janus Henderson Group Plc (April’25 Edition)

Shots:   Welcome to the 2025 series of Know Your Investor, featuring top venture capital firms focused on healthcare. This edition highlights Janus Henderson Group Plc, a global investment firm managing approximately $378.7B in assets across Equities, Fixed Income, Multi-Asset, and Alternatives. In 2024, the firm invested $5.36B across six funding rounds, adding 39 healthcare and…
April 3, 2025

Read more

PharmaShots' Key Highlights of Second Quarter 2022
INSIGHTS+

PharmaShots’ Key Highlights of Second Quarter 2022

The second quarter of 2022 highlights major acquisitions in the pharma and biotech industry along with multiple approvals. Meanwhile, AstraZeneca’s Farxiga (dapagliflozin) meet its primary endpoints for heart failure with a preserved ejection fractionStarting with the latest acquisitions, Pfizer acquire Biohaven for ~$11.6B, GSK acquire Affinivax for ~$3.3B. The second quarter of the year…
June 30, 2022

Read more